By Sulaiman Abdur-Rahman | August 21, 2024
"We continue to be proud to partner with Mayor [Brandon] Scott and the City of Baltimore to fight this deadly epidemic and bring justice to everyone affected by it," Susman Godfrey partner Bill Carmody said in a statement.
The Legal Intelligencer | News
By Riley Brennan | August 15, 2024
"We are delighted that Ram has been fully vindicated of these meritless allegations," former Mylan executive Ramkumar V. Rayapureddy's lead counsel, Adam Lurie, a partner at Linklaters, said of the outcome. "He has shown remarkable courage and resilience throughout this long injustice and is looking forward to moving on with his life and his career."
By Sulaiman Abdur-Rahman | August 14, 2024
"Novartis has not established on the current record that it is likely to suffer irreparable harm if injunctive relief is not granted," U.S. District Judge Dabney L. Friedrich wrote in her memorandum opinion denying Novartis's motion for a preliminary injunction without prejudice.
By Sulaiman Abdur-Rahman | August 9, 2024
"A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998," according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
By Maydeen Merino | July 9, 2024
The agency voted 4-1 to issue the report on pharmacy benefit managers, with Republican Commissioner Melissa Holyoak being the sole dissenter.
By Kat Black | June 11, 2024
A $700 million settlement reached by Johnson & Johnson with attorneys general from 43 states prohibits the pharmaceutical company from manufacturing, selling or distributing its talcum-based body powder products, which are known to increase the risk for cancer, in the United States.
Connecticut Law Tribune | News
By Emily Cousins | May 22, 2024
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
By Chris O'Malley | May 17, 2024
"I think the industry would like more clarity from the FDA on what exactly its position is on its authority over social media," said Mahnu Davar, a partner at Arnold & Porter Kaye Scholer.
By Brian Lee | May 3, 2024
The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
By Ellen Bardash | April 5, 2024
U.S. District Judge Angel Kelley wrote that Latham & Watkins-repped Homology Medicines Inc. "had no duty to disclose data in real time."
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Philadelphia Plaintiff litigation firm seeks an associate attorney with at least 2 years' experience to join our team handling personal inju...
Position OverviewThe United States Judicial Panel on Multidistrict Litigation is accepting applications for the full-time, permanent positio...
A prominent AV-rated Education Law firm seeks an associate with 5+ years experience. The role will primarily involve advice and counsel in ...